Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Total 13F shares
-
45,934,145
-
Share change
-
-2,876,768
-
Total reported value
-
$190,627,988
-
Put/Call ratio
-
0%
-
Price per share
-
$4.15
-
Number of holders
-
82
-
Value change
-
-$18,795,957
-
Number of buys
-
38
-
Number of sells
-
62
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q2 2022
As of 30 Jun 2022,
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,934,145 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, NEA Management Company, LLC, RA CAPITAL MANAGEMENT, L.P., FEDERATED HERMES, INC., BAKER BROS. ADVISORS LP, GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, FRANKLIN RESOURCES INC, and ALKEON CAPITAL MANAGEMENT LLC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.